Lewis Brisbois, Weil Guide $335M Cancer Biotech SPAC Deal
By Renee Hickman ( January 9, 2023, 5:58 PM EST) -- Clinical-stage biotechnology company Calidi Biotherapeutics and special-purpose acquisition company First Light announced on Monday that they entered into a merger agreement to create a public company worth $335 million focused on developing cancer therapies, in a deal driven by Lewis Brisbois Bisgaard & Smith LLP and Weil Gotshal & Manges LLP....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.